TY - JOUR
T1 - Psoriasis and obstructive sleep apnea
AU - Shalom, Guy
AU - Dreiher, Jacob
AU - Cohen, Arnon
N1 - Publisher Copyright:
© 2016 The International Society of Dermatology
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Background: Psoriasis is a chronic inflammatory skin disorder that is associated with the metabolic syndrome and its components. An association between obstructive sleep apnea (OSA) and the metabolic syndrome was previously observed. Objectives: To investigate the association between psoriasis and OSA in a comprehensive community-based database. Materials and methods: The study was performed utilizing the medical database of Clalit Health Services. Patients with psoriasis were compared to controls regarding the prevalence of OSA in a case–control study. A logistic multivariate model was used to control for independent covariates. Results: The study included 12,336 patients with psoriasis ≥21 years and 24,008 age- and sex-matched controls. The prevalence of OSA in patients with psoriasis was increased compared to the control group (2.7%, 1.5%, respectively, P < 0.001). Multivariate analysis adjusting for age, sex, ethnicity, body mass index, chronic obstructive pulmonary disease, hypothyroidism, hyperlipidemia, and peptic disease demonstrated a significant association between psoriasis and OSA (odds ratio = 1.27, 95% confidence interval 1.08–1.49, P < 0.001). Conclusion: We found an association between psoriasis and OSA among a large cohort of patients with psoriasis. Clinicians should take into account that patients with psoriasis may have undiagnosed OSA.
AB - Background: Psoriasis is a chronic inflammatory skin disorder that is associated with the metabolic syndrome and its components. An association between obstructive sleep apnea (OSA) and the metabolic syndrome was previously observed. Objectives: To investigate the association between psoriasis and OSA in a comprehensive community-based database. Materials and methods: The study was performed utilizing the medical database of Clalit Health Services. Patients with psoriasis were compared to controls regarding the prevalence of OSA in a case–control study. A logistic multivariate model was used to control for independent covariates. Results: The study included 12,336 patients with psoriasis ≥21 years and 24,008 age- and sex-matched controls. The prevalence of OSA in patients with psoriasis was increased compared to the control group (2.7%, 1.5%, respectively, P < 0.001). Multivariate analysis adjusting for age, sex, ethnicity, body mass index, chronic obstructive pulmonary disease, hypothyroidism, hyperlipidemia, and peptic disease demonstrated a significant association between psoriasis and OSA (odds ratio = 1.27, 95% confidence interval 1.08–1.49, P < 0.001). Conclusion: We found an association between psoriasis and OSA among a large cohort of patients with psoriasis. Clinicians should take into account that patients with psoriasis may have undiagnosed OSA.
UR - http://www.scopus.com/inward/record.url?scp=84989875899&partnerID=8YFLogxK
U2 - 10.1111/ijd.13367
DO - 10.1111/ijd.13367
M3 - Article
C2 - 27420909
AN - SCOPUS:84989875899
SN - 0011-9059
VL - 55
SP - e579-e584
JO - International Journal of Dermatology
JF - International Journal of Dermatology
IS - 11
ER -